HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary artery thrombolysis and stenting after a bilateral sequential lung transplantation.

Abstract
Bilateral sequential lung transplantation was complicated by pulmonary artery anastomotic stenosis and bilateral pulmonary thromboemboli. Pulmonary artery thrombus was eliminated by intrathrombotic but not by systemic administration of urokinase. The pulmonary emboli resulted in localized pulmonary infarctions, supporting the need for thrombolytic intervention to restore pulmonary perfusion in the absence of collateral bronchial blood flow after lung transplantation. Pulmonary artery stenosis was relieved by endovascular stenting, avoiding an early reoperative procedure. This case suggests that direct administration of thrombolytic agent may be superior to intravenous administration in the treatment of pulmonary thromboemboli. Pulmonary arterial anastomotic stenoses after lung transplantation can be relieved by endovascular procedures.
AuthorsM Bousamra 2nd, M W Mewissen, J Batter, K W Presberg, D P Schlueter, G B Haasler
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 16 Issue 6 Pg. 678-80 (Jun 1997) ISSN: 1053-2498 [Print] United States
PMID9229299 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Urokinase-Type Plasminogen Activator
Topics
  • Adult
  • Anastomosis, Surgical
  • Angiography
  • Arteriovenous Malformations (diagnostic imaging, surgery)
  • Constriction, Pathologic (diagnostic imaging, therapy)
  • Female
  • Humans
  • Lung Transplantation (physiology)
  • Postoperative Complications (diagnostic imaging, therapy)
  • Pulmonary Artery (abnormalities, diagnostic imaging, drug effects)
  • Pulmonary Embolism (diagnostic imaging, therapy)
  • Retreatment
  • Stents
  • Thrombolytic Therapy
  • Urokinase-Type Plasminogen Activator (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: